3-(4-bromophenyl)-7-fluoro-2H-pyrrolo[1,2-a]pyrazin-1-one;7-fluoro-3-[4-(5-hydroxypent-1-en-2-yl)phenyl]-2H-pyrrolo[1,2-a]pyrazin-1-one;7-fluoro-3-[4-(2-methyloxolan-2-yl)phenyl]-2H-pyrrolo[1,2-a]pyrazin-1-one;pent-4-en-1-ol
C54H52BrF3N6O6 — CID 159444518
Data last refreshed: (MolForge compound catalog, from PubChem)
About 3-(4-bromophenyl)-7-fluoro-2H-pyrrolo[1,2-a]pyrazin-1-one;7-fluoro-3-[4-(5-hydroxypent-1-en-2-yl)phenyl]-2H-pyrrolo[1,2-a]pyrazin-1-one;7-fluoro-3-[4-(2-methyloxolan-2-yl)phenyl]-2H-pyrrolo[1,2-a]pyrazin-1-one;pent-4-en-1-ol
3-(4-bromophenyl)-7-fluoro-2H-pyrrolo[1,2-a]pyrazin-1-one;7-fluoro-3-[4-(5-hydroxypent-1-en-2-yl)phenyl]-2H-pyrrolo[1,2-a]pyrazin-1-one;7-fluoro-3-[4-(2-methyloxolan-2-yl)phenyl]-2H-pyrrolo[1,2-a]pyrazin-1-one;pent-4-en-1-ol (PubChem CID 159444518) has the molecular formula C54H52BrF3N6O6 and a molecular weight of 1017.94 g/mol. Its IUPAC name is 3-(4-bromophenyl)-7-fluoro-2H-pyrrolo[1,2-a]pyrazin-1-one;7-fluoro-3-[4-(5-hydroxypent-1-en-2-yl)phenyl]-2H-pyrrolo[1,2-a]pyrazin-1-one;7-fluoro-3-[4-(2-methyloxolan-2-yl)phenyl]-2H-pyrrolo[1,2-a]pyrazin-1-one;pent-4-en-1-ol.
Molecular Properties
| Compound Name | 3-(4-bromophenyl)-7-fluoro-2H-pyrrolo[1,2-a]pyrazin-1-one;7-fluoro-3-[4-(5-hydroxypent-1-en-2-yl)phenyl]-2H-pyrrolo[1,2-a]pyrazin-1-one;7-fluoro-3-[4-(2-methyloxolan-2-yl)phenyl]-2H-pyrrolo[1,2-a]pyrazin-1-one;pent-4-en-1-ol |
|---|---|
| PubChem CID | 159444518 |
| Molecular Formula | C54H52BrF3N6O6 |
| Molecular Weight | 1017.94 g/mol |
| Exact Mass | 1016.31 |
| IUPAC Name | 3-(4-bromophenyl)-7-fluoro-2H-pyrrolo[1,2-a]pyrazin-1-one;7-fluoro-3-[4-(5-hydroxypent-1-en-2-yl)phenyl]-2H-pyrrolo[1,2-a]pyrazin-1-one;7-fluoro-3-[4-(2-methyloxolan-2-yl)phenyl]-2H-pyrrolo[1,2-a]pyrazin-1-one;pent-4-en-1-ol |
| SMILES | C=C(CCCO)c1ccc(-c2cn3cc(F)cc3c(=O)[nH]2)cc1.C=CCCCO.CC1(c2ccc(-c3cn4cc(F)cc4c(=O)[nH]3)cc2)CCCO1.O=c1[nH]c(-c2ccc(Br)cc2)cn2cc(F)cc12 |
| InChI | InChI=1S/2C18H17FN2O2.C13H8BrFN2O.C5H10O/c1-18(7-2-8-23-18)13-5-3-12(4-6-13)15-11-21-10-14(19)9-16(21)17(22)20-15;1-12(3-2-8-22)13-4-6-14(7-5-13)16-11-21-10-15(19)9-17(21)18(23)20-16;14-9-3-1-8(2-4-9)11-7-17-6-10(15)5-12(17)13(18)16-11;1-2-3-4-5-6/h3-6,9-11H,2,7-8H2,1H3,(H,20,22);4-7,9-11,22H,1-3,8H2,(H,20,23);1-7H,(H,16,18);2,6H,1,3-5H2 |
| InChIKey | LSPFNMUBSJBDSL-UHFFFAOYSA-N |
| XLogP | 10.82 |
| TPSA | 161.50 Ų |
| H-Bond Donors | 5 |
| H-Bond Acceptors | 9 |
| Rotatable Bonds | 11 |
| Heavy Atoms | 70 |
| Complexity | — |
Lipinski Rule of Five
2 violations
| Rule | Value |
|---|---|
| MW ≤ 500 | 1017.94 |
| LogP ≤ 5 | 10.82 |
| H-Bond Donors ≤ 5 | 5 |
| H-Bond Acceptors ≤ 10 | 9 |
Computed Properties (RDKit)
| Structural Alerts | {'alert_name': 'Aliphatic_long_chain', 'substructure': 'N/A'}, {'alert_name': 'isolated_alkene', 'substructure': 'N/A'} |
|---|
Frequently Asked Questions
Browse: Molecules A–Z · all molecules A–Z · drugs A–Z · protein targets A–Z.
Sources
- PubChem CID 159444518 — identifiers, structure, computed properties (public domain)
How this page is built: methodology · editorial policy & corrections.
For research and educational use only — not medical advice. This page is compiled automatically from public databases. It is not written or reviewed by a clinician. Do not start, stop or change any treatment based on it; consult a qualified healthcare professional. Spotted an error? See our corrections policy or email hello@molforge.ai.